Dr. Alfred Reszka, Merck & Co.
Dr. Alfred Reszka, Executive Director and Head, Strategic Business Intelligence, Merck & Co.
Alfred “Al” Reszka is Executive Director and Head, Strategic Business Intelligence at Merck. He and his team include clients from R&D to marketing and manufacturing across a variety of business functions requiring scientific, medical and business intelligence. Roles and responsibilities include strategic benchmarking and strategy development, product surveillance, biosimilars, Diversified Brands, emerging markets, Osteoporosis and women’s health licensing, business development, and M&A.
Prior to joining the Global Competitive Intelligence group in 2007, Dr. Reszka was Senior Research Fellow in Bone Basic Research at Merck, where he conducted research into the mechanism of action of FOSAMAX and lead the drug discovery effort. He joined Merck in 1997 after conducting postdoctoral research on molecular signal transduction with Nobel Laureates, Edmund Fischer and Edwin Krebs at the University of Washington in Seattle. Dr. Reszka earned his PhD in 1992 at the University of Illinois, Champaign-Urbana.